These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7016802)

  • 21. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double blind comparative trial of viloxazine and amitriptyline in patients suffering from endogenous depression.
    Kiloh LG; Bartrop RW; Franklin JA; Neilson MD
    Aust N Z J Psychiatry; 1979 Dec; 13(4):357-60. PubMed ID: 395939
    [No Abstract]   [Full Text] [Related]  

  • 23. Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jun; 13(6):401-21. PubMed ID: 324751
    [No Abstract]   [Full Text] [Related]  

  • 24. [Double-blind trial of 2 antidepressive drugs].
    De León O; Kravcio JT; Sánchez C
    Acta Psiquiatr Psicol Am Lat; 1977 Sep; 23(3):215-20. PubMed ID: 341650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
    Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viloxazine and amitriptyline in depressive illness. A double blind controlled trial in general practice.
    Lennox IG; Asbury JF; Couldrick WG; Beswick KB
    Practitioner; 1978 Jan; 220(1315):153-6. PubMed ID: 343090
    [No Abstract]   [Full Text] [Related]  

  • 27. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
    Altamura AC; Mauri MC; Guercetti G
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcoholism and depression: a placebo controlled study with viloxazine.
    Altamura AC; Mauri MC; Girardi T; Panetta B
    Int J Clin Pharmacol Res; 1990; 10(5):293-8. PubMed ID: 2079386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
    Maistrello I; Grassi G; Bertolino A; Valerio P; Pistollato G; Soverini S
    Adv Biochem Psychopharmacol; 1982; 32():369-73. PubMed ID: 7090902
    [No Abstract]   [Full Text] [Related]  

  • 30. A double blind comparison of lofepramine, imipramine and placebo in patients with depression.
    Feighner JP; Meridith CH; Dutt JE; Hendrickson GG
    Acta Psychiatr Scand; 1982 Aug; 66(2):100-8. PubMed ID: 6753500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly.
    Moizeszowicz J; Subirá S
    J Clin Pharmacol; 1977 Jan; 17(1):81-3. PubMed ID: 319120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of depressive conditions with viloxazine by the general practitioner].
    Haehn KD
    Fortschr Med; 1985 Apr; 103(15):408-12. PubMed ID: 3997018
    [No Abstract]   [Full Text] [Related]  

  • 33. Double-blind trial of sustained-release amitriptyline compared with viloxazine in moderate to severe depressive illness.
    Sedman G
    Curr Med Res Opin; 1977; 5(3):217-25. PubMed ID: 162657
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical trials of viloxazine in depressive states].
    Fontan M; Goudemand M; Pellerin-Millecamps E
    Encephale; 1979; 5(3):243-9. PubMed ID: 385296
    [No Abstract]   [Full Text] [Related]  

  • 35. [The antidepressant viloxazin. A multicenter study under practice conditions].
    Rüther E
    Fortschr Med; 1982 May; 100(18):864-70. PubMed ID: 6124490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Doubleblind study with the novel antidepressant viloxazine versus imipramine in 50 in-patients (author's transl)].
    Floru L; Czarny G; Tegeler J
    Arzneimittelforschung; 1976; 26(6):1170-1. PubMed ID: 786314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of maprotiline (Ludiomil) and viloxazine in the management of depressed patients in general practice.
    Lomas DM
    J Int Med Res; 1977; 5 Suppl 4():39-50. PubMed ID: 338401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do have antidepressants of the second generation anxiolytic properties?
    Kabes J; Dostal T; Balon R
    Agressologie; 1981 Nov; 22(E):11-3. PubMed ID: 7332041
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders.
    Merideth CH; Feighner JP
    Acta Psychiatr Scand Suppl; 1983; 308():70-9. PubMed ID: 6230897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug therapy profile of viloxazine. Open clinical trial with 34 patients].
    Pérez de Francisco C
    Neurol Neurocir Psiquiatr; 1976; 17(2):115-21. PubMed ID: 1052716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.